Pharmiva AB (publ)

At a glance

Most recent filing on January 3, 2023 — an open-market purchase by Anna Linton on Jan 3, 2023.

We hold 15 visible filings, going back to March 30, 2021.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 15 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 15. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Anna Linton Chief executive officer
29,750 SEKOpen-market buy
TradedJan 3, 2023FiledJan 3, 2023
Anna Linton Chief executive officer
7,665 SEKOpen-market buy
TradedJan 2, 2023FiledJan 3, 2023
Anna Linton Chief executive officer
31,251 SEKOpen-market buy
TradedDec 20, 2022FiledDec 22, 2022
Malte Zaunders Chair of the board
90,469 SEKOpen-market buy
TradedMay 25, 2021FiledMay 26, 2021
Malte Zaunders Chair of the board
1,795 SEKOpen-market buy
TradedMay 25, 2021FiledMay 26, 2021